RPRX

Repros Therapeutics Inc.
RPRX

Overview Fund Activity
Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

53 hedge funds and large institutions have $7.91M invested in Repros Therapeutics Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 20 reducing their positions, and 9 closing their positions.

Holders
53
Holders Change
-3
Holders Change %
-5.36%
% of All Funds
1.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
20
Closed
9
Calls
$207K
Puts
$72K
Net Calls
+$135K
Net Calls Change
-$87K

Top Buyers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$314K
2
GCM
2
Gruss Capital Management
New York
$582K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$172K
4
GCP
4
GSA Capital Partners
United Kingdom
$27K
5
Nomura Holdings
5
Nomura Holdings
Japan
$17K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$2.22M
2
Millennium Management
2
Millennium Management
New York
$403K
3
ARTA
3
A.R.T. Advisors
New York
$0
4
RA
4
Royce & Associates
New York
$0
5
Goldman Sachs
5
Goldman Sachs
New York
$55K
Name Holding Trade Value Shares
Change 		Shares
Change %
ARTA
51
A.R.T. Advisors
New York
– -$220K -182,501 Closed
RA
52
Royce & Associates
New York
– -$156K -129,000 Closed
CC
53
CQS Cayman
Cayman Islands
– -$109K -90,000 Closed
CS
54
Credit Suisse
Switzerland
– -$85K -70,375 Closed
Susquehanna International Group
55
Susquehanna International Group
Pennsylvania
– -$31K -25,423 Closed
PAM
56
Panagora Asset Management
Massachusetts
– -$5K -3,823 Closed
TRCT
57
Tower Research Capital (TRC)
New York
– -$4K -3,315 Closed
Parallax Volatility Advisers
58
Parallax Volatility Advisers
California
– -$2K -1,559 Closed
1 2
3